First prospective, multi-centre clinical experience with a novel left ventricular quadripolar lead

Europace

Volumn 14, Issue 3, 2012, Pages 365-372

  Sperzel, Johannes ^a   Dänschel, Wilfried ^b   Gutleben, Klaus Jürgen ^c   Kranig, Wolfgang ^d   Mortensen, Peter ^e   Connelly, Derek ^f   Trappe, Hans Joachim ^g   Seidl, Karlheinz ^h   Duray, Gabor ⁱ   Pieske, Burkert ^j   Stockinger, Jochem ^k   Boriani, Giuseppe ^l   Jung, Werner ^m   Schilling, Richard ⁿ   Saberi, Linda ^o   Hallier, Benoit ^p   Simon, Marcus ^p   Rinaldi, Christopher A ^q  

^a KERCKHOFF HEART CENTER   (Germany)

^b Medizinisches Versorgungszentrum   (Germany)

^c RUHR UNIVERSITY BOCHUM   (Germany)

^d Schuchtermann Klinik   (Germany)

^e AARHUS UNIVERSITY HOSPITAL   (Denmark)

^f GOLDEN JUBILEE NATIONAL HOSPITAL   (United Kingdom)

^g RUHR UNIVERSITY BOCHUM   (Germany)

^h KLINIKUM LUDWIGSHAFEN   (Germany)

ⁱ UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^j UNIVERSITY HOSPITAL GRAZ   (Austria)

^k UNIVERSITY HEART CENTER FREIBURG BAD KROZINGEN   (Germany)

^l UNIVERSITY OF BOLOGNA   (Italy)

^m Klinikum der Stadt in Villingen Schwenningen   (Germany)

ⁿ ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^o ST JUDE MEDICAL   (United States)

^p St Jude Medical EMEAC   (Belgium)

^q ST THOMAS HOSPITAL   (United Kingdom)

more..

Author keywords

Cardiac resynchronization therapy; Left ventricular pacing; LV lead complications; Phrenic nerve stimulation; Quadripolar lead

Indexed keywords

AGED; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CARDIAC RESYNCHRONIZATION THERAPY DEVICE; CORONARY SINUS; DEFIBRILLATOR; ELECTRODE; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VENTRICLE PACING; HUMAN; IMPLANTATION; MAJOR CLINICAL STUDY; MORTALITY; MULTICENTER STUDY; NERVE STIMULATION; PACEMAKER; PHRENIC NERVE; PRIORITY JOURNAL; QUADRIPOLAR ELECTRODE LEAD;

AGED; CARDIAC RESYNCHRONIZATION THERAPY DEVICES; ELECTRODES, IMPLANTED; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PHRENIC NERVE; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84857835355     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eur322     Document Type: Article

References (27)

1. Eriksson H. Heart failure: A growing public health problem. J Intern Med 1995;237: 135-41.
2. Cazeau S, Leclercq C, Lavergne T, Walker S, Varma C, Linde C et al. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med 2001;344:873-80. (Pubitemid 32224395)
3. Abraham WT, Fisher WG, Smith AL, Delurgio DB, Leon AR, Loh E et al. Cardiac resynchronization in chronic heart failure. N Engl J Med 2002;346:1845-53. (Pubitemid 34603028)
4. Cleland JGF, Daubert J-C, Erdmann E, Freemantle N, Gras D, Kappenberger L et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005;352:1539-49. (Pubitemid 40517094)
5. Anand IS, Carson P, Galle E, Song R, Boehmer J, Ghali JK et al. Cardiac resynchronization therapy reduces the risk of hospitalizations in patients with advanced heart failure: Results from the Comparison of Medical Therapy, Pacing and Defibrillation in Heart Failure (COMPANION) trial. Circulation 2009;119:969-77.
6. Moss AJ, Hall WJ, Cannom DS, Klein H, Brown MW, Daubert JP et al. Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med 2009;361:1329-38.
7. Vardas PE, Auricchio A, Blanc J-J, Daubert J-C, Drexler H, Ector H et al. Guidelines for cardiac pacing and cardiac resynchronization therapy. Europace 2007;9: 959-98.
8. Authors/Task Force Members, Dickstein K, Vardas PE, Auricchio A, Daubert J-C, Linde C et al. 2010 Focused Update of ESC Guidelines on device therapy in heart failure. Europace 2010;12:1526-36.
9. Morgan JM, Delgado V. Lead positioning for cardiac resynchronization therapy: Techniques and priorities. Europace 2009;11(Suppl 5):v22-8.
10. Ritter P, Cazeau S, Gras D, Daubert J-C. Cardiac resynchronization therapy implantation: A blend of skill and technology. Eur Heart J Suppl 2007;9(Suppl I): I107-12.
11. Gras D, Böcker D, Lunati M, Wellens HJJ, Calvert M, Freemantle N et al. Implantation of cardiac resynchronization therapy systems in the CARE-HF trial: Procedural success rate and safety. Europace 2007;9:516-22. (Pubitemid 47249440)
12. Borleffs CJW, van Bommel RJ, Molhoek SG, de Leeuw JG, Schalij MJ, van Erven L. Requirement for coronary sinus lead interventions and effectiveness of endovascular replacement during long-term follow-up after implantation of a resynchronization device. Europace 2009;11:607-11.
13. Biffi M, Moschini C, Bertini M, Saporito D, Ziacchi M, Diemberger I et al. Phrenic stimulation: A challenge for cardiac resynchronization therapy. Circ Arrhythm Electrophysiol 2009;2:402-10.
14. Ypenburg C, Vanbommel R, Delgado V, Mollema S, Bleeker G, Boersma E et al. Optimal left ventricular lead position predicts reverse remodeling and survival after cardiac resynchronization therapy. J Am Coll Cardiol 2008;52:1402-9.
15. Dickstein K, Bogale N, Priori S, Auricchio A, Cleland JG, Gitt A et al. The european cardiac resynchronization therapy survey. Eur Heart J 2009;30:2450-60.
16. Forleo GB, Della Rocca DG, Papavasileiou LP, Molfetta AD, Santini L, Romeo F. Left ventricular pacing with a new quadripolar transvenous lead for CRT: Early results of a prospective comparison with conventional implant outcomes. Heart Rhythm 2011;8:31-7.
17. Tang ASL, Wells GA, Talajic M, Arnold MO, Sheldon R, Connolly S et al. Cardiac-resynchronization therapy for mild-to-moderate heart failure. N Engl J Med 2010;363:2385-95.
18. Duray GZ, Hohnloser SH, Israel CW. Coronary sinus side branches for cardiac resynchronization therapy: Prospective evaluation of availability, implant success, and procedural determinants. J Cardiovasc Electrophysiol 2008;19:489-94. (Pubitemid 351623918)
19. Gold MR, Auricchio A, Hummel JD, Giudici MC, Ding J, Tockman B et al. Comparison of stimulation sites within left ventricular veins on the acute hemodynamic effects of cardiac resynchronization therapy. Heart Rhythm 2005;2:376-81. (Pubitemid 40439283)
20. Balasundaram R, Rao HB, Sridevi C, Somaraju B, Singh B, Calambur N. Hemodynamic benefit of multiple programmable pacing configurations in patients with biventricular pacemakers. Pacing Clin Electrophysiol 2009;32:S211-3.
21. Merchant FM, Heist EK, McCarty D, Kumar P, Das S, Blendea D et al. Impact of segmental left ventricle lead position on cardiac resynchronization therapy outcomes. Heart Rhythm 2010;7:639-44.
22. Merchant FM, Heist EK, Nandigam KV, Mulligan LJ, Blendea D, Riedl L et al. Interlead distance and left ventricular lead electrical delay predict reverse remodeling during cardiac resynchronization therapy. Pacing Clin Electrophysiol 2010;33: 575-82.
23. Singh JP, Fan D, Heist EK, Alabiad CR, Taub C, Reddy V et al. Left ventricular lead electrical delay predicts response to cardiac resynchronization therapy. Heart Rhythm 2006;3:1285-92. (Pubitemid 44615674)
24. Khan FZ, Virdee MS, Fynn SP, Dutka DP. Left ventricular lead placement in cardiac resynchronization therapy: Where and how? Europace 2009;11:554-61.
25. Bleeker GB, Kaandorp TAM, Lamb HJ, Boersma E, Steendijk P, de Roos A et al. Effect of posterolateral scar tissue on clinical and echocardiographic improvement after cardiac resynchronization therapy. Circulation 2006;113:969-76. (Pubitemid 43879472)
26. León AR, Abraham WT, Curtis AB, Daubert JP, Fisher WG, Gurley J et al. Safety of transvenous cardiac resynchronization system implantation in patients with chronic heart failure: Combined results of over 2,000 patients from a multicenter study program. J Am Coll Cardiol 2005;46:2348-56. (Pubitemid 41785509)
27. Crossley GH, Exner D, Mead RH, Sorrentino RA, Hokanson R, Li S et al. Chronic performance of an active fixation coronary sinus lead. Heart Rhythm 2010;7: 472-8.